Project Team Meeting: Agendas & Minutes

Our Project Team Meetings are held every Tuesday, 17:00-18:00 (Central European Time)

If you would like to participate, contact the Project Manager: richard.norman@pistoiaalliance.org

Name	Organisation	Location	Role	Relevant experience & interests
Francisco J. Fernández	Abvance Biotech	Madrid, ES	Chief Executive Officer	CEO. Structural biologist. Scientific leadership to the antibody drug discovery, business strategy and partnering programmes.
Jocelyne Fiaux	Novartis	Basel, CH	Head Strategy and Operations Integrated Biologics Profiling	Background in protein chemistry. Experience in biochemical and biophysical characterization, and Developability Assessment of therapeutic proteins and antibodies.
Laura Hook	GSK	Stevenage, UK
Bryan Jones	Eli Lilly	San Diego, US	Research Fellow	Group Leader for Protein Bio-Sciences group, responsible for expression, purification, biochemical and biophysical characterization of potential therapeutic proteins and antibodies.
Chris Lloyd	MedImmune	Cambridge, UK		Protein engineer. Research Developability lead for MedImmune. Works on mAbs, bispecific's, ADCs and other novel formats across various therapy areas
Carmen Nitsche	Pistoia Alliance		Business Development Lead
Richard Norman	Pistoia Alliance	Gjøvik, NO	Consultant Project Manager	Project Manager. Background in structural biology, and small molecule drug discovery and early development at AstraZeneca. Interested in drug development of biologics, data sharing and the impact which Machine Learning and Artificial Intelligence will have on the Life Sciences.
Abhinandan Raghavan	Novartis	Basel, CH
Kieran Todd	GSK	Stevenage, UK	Senior Investigator	Bioinformatician providing support to all aspect of the antibody development process, ranging from target identification through to patent support but most heavily focused on lead molecule identification and/or design.

Browser not supported